Understanding which type suits your needs is important for better results
But, for the most part, patients following standard protocol start with .25mg for the first four weeks and double the dosage in four-week increments until week 13 (e.g., 0.5mg weeks 5-8, 1mg weeks 9-12)
There are no clinical trials on this approach it's based on pharmacokinetic modelling and community experience
Chan, J
Clinical trials and real-world data support safety and effectiveness in adults over 65, though kidney function and other age-related health factors require evaluation
It is under investigation in preclinical and clinical studies on overweight, obesity, and metabolic disorders, where researchers have examined its effects on body weight and energy intake, including when combined with GLP 1 receptor agonists such as semaglutide, but it is not an approved therapy